A poorly performing antibody can cost far more than its purchase price. Repeated experiments, additional reagents, extensive troubleshooting and project delays can all contribute to research costs that are often overlooked.
But what is the true impact on research efficiency and reproducibility?
In our whitepaper, The real cost of poorly validated antibodies, we explore the financial and scientific consequences of antibody-related research waste. Drawing on an industry analysis by NeoBiotechnologies and published scientific literature, we examine why proper antibody validation matters and how informed antibody selection can help reduce experimental risks.
Download the whitepaper to learn more about:
- The hidden costs of poorly validated antibodies
- The impact on research progress and reproducibility
- The importance of application-specific antibody validation
Reliable antibodies, backed by scientific expertise
At Sanbio, we support researchers in selecting suitable antibodies through scientific guidance and access to specialised manufacturers. Our Sanbio Antibody Promise provides additional confidence by standing behind antibody performance in accordance with the manufacturer's datasheet and our terms and conditions.
